Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With Achondroplasia [Phase 2]

View source ↗

Summary

Phase 2 study evaluating SAR442501 in pediatric achondroplasia assessing safety, tolerability, pharmacokinetics/pharmacodynamics, and efficacy; the trial was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia
• Osteochondrodysplasia

Drugs mentioned

• SAR442501

Snippet

Sponsor: Sanofi | Conditions: Osteochondrodysplasia | Phase 2 | Status: TERMINATED